Nelson N. Ayangho

FDA investigator

Appears on 2 documents from 2025 to 2026, mostly at sites in Tennessee. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110(a)).

2
Documents on file
4.0
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 8 observations

Activity by year

2025: 1, 2026: 1

Where

Tennessee 2

Is Nelson N. Ayangho coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 The Harvard Drug Group LLC dba MajorMar 20, 2026 · La Vergne, Tennessee
483 Dee Cee Laboratories, IncAug 11, 2025 · White House, Tennessee

About this profile

What does Nelson N. Ayangho inspect?

Nelson N. Ayangho appears on 2 documents on file covering 2 sites, mostly in Tennessee.

What do they cite most often?

21 CFR 211.110(a) (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.22(d) and 21 CFR 211.166(c)(1).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Nelson N. Ayangho is dated Mar 20, 2026.